Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangdong Marubi Biotechnology Co EV-to-FCF?
Guangdong Marubi Biotechnology CoSHSE:603983 +2.14%71 EV-to-FCF is 80.96 as of Jul. 31, 2026, which is 251% above its 10-year median of 23.07. GuruFocus rates SHSE:603983 with a GF Score™ of 71/100 and a GF Value™ of ¥45.12 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,194 Consumer Packaged Goods companies, Guangdong Marubi Biotechnology Co ranks worse than 90.7% on this metric.
SHSE:603983'
s EV-to-FCF Range Over the Past 10 Years
Min: -850.11 Med: 23.07 Max: 419.82
Current: 86.7
During the past 13 years, the highest EV-to-FCF of Guangdong Marubi Biotechnology Co was 419.82. The lowest was -850.11. And the median was 23.07.
SHSE:603983's EV-to-FCF is ranked worse than 90.7% of 1194
companies
in the Consumer Packaged Goods industry
Industry Median: 16.155
vs SHSE:603983: 86.70
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guangdong Marubi Biotechnology Co (SHSE:603983) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guangdong Marubi Biotechnology Co's PE Ratio (TTM) for today is calculated as:
Guangdong Marubi Biotechnology Co's share price for today is ¥28.67.
Guangdong Marubi Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.530.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Guangdong Marubi Biotechnology Co EV-to-FCF Related Terms
Guangdong Marubi Biotechnology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Guangdong Marubi Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Marubi Biotechnology Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Marubi Biotechnology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Guangdong Marubi Biotechnology Co's EV-to-FCF falls into.
Guangdong Marubi Biotechnology Co's current Enterprise Value is ¥10,127 Mil.
Guangdong Marubi Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥125 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Marubi Biotechnology Co (SHSE:603983) has a EV-to-FCF of 80.96 as of Jul. 31, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guangdong Marubi Biotechnology Co and its competitors. This is 251% above median its historical median of 23.07. According to the industry distribution chart, Guangdong Marubi Biotechnology Co ranks #1083 out of 1194 companies in the Consumer Packaged Goods industry, placing it in the top 90.7%.
Is Guangdong Marubi Biotechnology Co's EV-to-FCF too high?
Guangdong Marubi Biotechnology Co's current EV-to-FCF of 80.96 is 251% above median its 10-year median of 23.07. The Consumer Packaged Goods industry median EV-to-FCF is 16.16. Guangdong Marubi Biotechnology Co's value of 80.96 is 401.1% above this industry median. Based on the distribution chart, Guangdong Marubi Biotechnology Co ranks #1083 out of 1194 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Guangdong Marubi Biotechnology Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Marubi Biotechnology Co's EV-to-FCF compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Marubi Biotechnology Co ranks #1083 out of 1194 companies for EV-to-FCF. This places Guangdong Marubi Biotechnology Co in the lower half of its industry. The industry median EV-to-FCF is 16.16. Guangdong Marubi Biotechnology Co's value of 80.96 is 401.1% above this benchmark. While the company's 10-year median is 23.07 vs. the industry median of 16.16, Guangdong Marubi Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 16.16, based on 1,194 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Marubi Biotechnology Co's current EV-to-FCF of 80.96 is 401.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guangdong Marubi Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 16.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Marubi Biotechnology Co's current EV-to-FCF is 80.96, which is 251% above median its own 10-year median of 23.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Marubi Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co (SHSE:603983) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥45.12, compared to a current price of ¥28.67 — trading 36.5% below its estimated fair value. The current EV-to-FCF is 80.96, which is 251% above median its 10-year median of 23.07 and 401.1% above the Consumer Packaged Goods industry median of 16.16. Guangdong Marubi Biotechnology Co's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Guangdong Marubi Biotechnology Co (SHSE:603983), the current EV-to-FCF is 80.96 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued.
The current stock price of ¥28.67 is trading 36.5% below its estimated GF Value™ of ¥45.12.
GuruFocus considers Guangdong Marubi Biotechnology Co to be Significantly Undervalued.
Key valuation signals for SHSE:603983:
EV-to-FCF: 80.96 (251% above median its 10-year median of 23.07)
GF Value™: ¥45.12 vs. price of ¥28.67 (36.5% below fair value)
Industry Position: 401.1% above the Consumer Packaged Goods median (#1083 of 1194)
No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603983 has been successfully added to your 
